GE Healthcare recently announced its completion of the acquisition of Whatman, which is a global supplier of filtration technologies and products.
GE Healthcare recently announced its completion of the acquisition of Whatman, which is a global supplier of filtration technologies and products.Expanding GE Healthcare's life science research and biopharmaceutical manufacturing contribution, the acquisition enhances a key area of growth for the company. A provider of cellular and protein science research technologies, as well as tools used in biopharmaceuticals' manufacture - products such as vaccines, cell therapies and antibodies - GE Healthcare will secure substantial customer benefits through the addition of Whatman's innovative filters and membranes for laboratory research, life sciences and medical technology applications.GE Healthcare's president and CEO of life sciences business commented: "Whatman's expertise and reputation on filtration technologies and sample preparation is a great fit for our life sciences business. We believe that combining the skills of the two companies will enable GE Healthcare to create strong added value for customers in biomedical and drug discovery research."
Navigating the Impact of Funding Cuts: Voices from the Research Community
July 9th 2025Shifts in U.S. federal science funding—driven by the newly established Department of Government Efficiency (DOGE)—are causing delays, uncertainty, and program changes across academic and regulatory research institutions.
FDA Grants Breakthrough Status to AI-Enhanced GC-MS Device for Bladder Cancer Detection
July 1st 2025A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas chromatography–mass spectrometry (GC–MS) and proprietary AI, generates real-time cancer risk scores.
Researchers Explore Comprehensive Modelling Approach for Liquid-Liquid Chromatography
June 30th 2025Scientists from the Technical University of Munich and Lund University explored the use of new models for liquid-liquid chromatography based off pre-existing procedures for liquid-liquid extraction.